Mark R. Davies
- Public Health, Environmental and Occupational Health top 1%
- Infectious Diseases top 1%
- Molecular Biology top 10%
- Epidemiology top 5%
- Molecular Medicine top 0.5%
- Co-authors
- Mark J. WalkerMarjan W. van der WoudeGordon DouganDavid J. McMillanKadaba S. SriprakashMichael F. GoodMichael R. BatzloffNouri L. Ben Zakour
- Topics
- Streptococcal Infections and Treatments (67 papers)Antimicrobial Resistance in Staphylococcus (44 papers)Neonatal and Maternal Infections (28 papers)
- Journals
- Proceedings of the National Academy of SciencesNucleic Acids ResearchJournal of Biological Chemistry
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Mark R. Davies
110 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Public Health, Environmental and Occupational Health 1.4k
- Infectious Diseases 1.2k
- Molecular Biology 761
- Epidemiology 632
- Molecular Medicine 507
Countries citing papers authored by Mark R. Davies
This map shows the geographic impact of Mark R. Davies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Davies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Davies more than expected).
Fields of papers citing papers by Mark R. Davies
This network shows the impact of papers produced by Mark R. Davies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Davies. The network helps show where Mark R. Davies may publish in the future.
Co-authorship network of co-authors of Mark R. Davies
This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Davies. A scholar is included among the top collaborators of Mark R. Davies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Davies. Mark R. Davies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 7 | |
| 4 | 12 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 6 | |
| 8 | 9 | |
| 9 | Pathogenesis, epidemiology and control of Group A Streptococcus infectionbreakdown → | 146 |
| 10 | 8 | |
| 11 | 34 | |
| 12 | 5 | |
| 13 | 5 | |
| 14 | 50 | |
| 15 | 46 | |
| 16 | 4 | |
| 17 | 58 | |
| 18 | Draft Genome Sequence of Roseomonas mucosa Strain AU37, Isolated from a Peripheral Intravenous Catheter | 0 |
| 19 | 97 | |
| 20 | 27 |
About Mark R. Davies
Mark R. Davies is a scholar working on Infectious Diseases, Endocrinology and Public Health, Environmental and Occupational Health, having authored 115 papers that have together received 3.2k indexed citations. Recurring topics across this work include Streptococcal Infections and Treatments (67 papers), Antimicrobial Resistance in Staphylococcus (44 papers) and Neonatal and Maternal Infections (28 papers). The work is most often cited by research in Molecular Medicine (507 citations), Endocrinology (472 citations) and Infectious Diseases (1.2k citations). Mark R. Davies has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Mark J. Walker, Marjan W. van der Woude, Gordon Dougan, David J. McMillan, Kadaba S. Sriprakash, Michael F. Good, Michael R. Batzloff, Nouri L. Ben Zakour, Steven Y. C. Tong and Magnus G. Jespersen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.